Citigroup Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $46
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsInitiationPrice Target
Citigroup analyst Yigal Nochomovitz initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Buy rating and announces Price Target of $46.
Citigroup analyst Yigal Nochomovitz initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Buy rating and announces Price Target of $46.